SOX2 and breast cancer: Specifically, the expression of NANOG and SOX2, which are demonstrated to drive tumorigenesis and metastasis in breast cancer [35,36], was 5-fold higher in CD44−/low/CD24−/low cells from luminal cell lines compared to CD44high/CD24−/low cells from Hs578T.